MASTER PLANT HOLDINGS LTD

Name

MASTER PLANT HOLDINGS LTD

Website

https://masterplant.co.uk

Company type

Private

Founded year

2020

Headcount range

11–50 employees

Short description

Master Plant Holdings is a London-based private company founded in 2020 that develops cannabis-derived wellness products, CBD consumer goods, and proprietary cannabinoid genetics for medical and research applications.

Ownership category

akta.pro rank

Product category

Cannabis & CBD Wellness Products

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles) (CRANAHAA)

akta.pro secondary industries

Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.) (CRANAFAJ), Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)

Keywords

• Cannabis wellness products
• CBD consumer goods
• Cannabinoid genetics
• Medical cannabis research
• Plant-based therapeutics

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Core offering

Master Plant Holdings develops cannabis-based wellness products and CBD consumer goods, and maintains proprietary cannabinoid genetics developed for medical and research use. The company's offerings combine finished cannabis-derived products for individual consumers with genetic assets that can support research buyers.

Differentiator

Problem solved

Functional benefit

Products and services

• Cannabis-Based Wellness Products Wellness-focused products derived from cannabis, developed for consumers seeking plant-based therapeutic and wellness options.
• CBD Consumer Goods Consumer products containing cannabidiol (CBD) intended for personal use by individual buyers.
• Proprietary Cannabinoid Genetics Proprietary cannabinoid genetic lines developed by the company for use in medical and research applications.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• GW Pharmaceuticals (Jazz Pharmaceuticals): GW Pharmaceuticals pioneered UK-based cannabinoid prescription medicines (Sativex, Epidiolex) and was acquired by Jazz Pharmaceuticals in 2021. It is the most established UK cannabis-derived therapeutics developer and represents the institutional benchmark Master Plant's medical/research ambition would need to approach.
• Charlotte's Web Holdings: Charlotte's Web is the largest US hemp-derived CBD wellness brand, built on proprietary hemp genetics. It is a useful analogue for the genetics-to-consumer model Master Plant describes, though it operates across the Atlantic under different regulations.

Direct peers

• British Cannabis: British Cannabis is a UK CBD manufacturer producing a broad range of consumer CBD oils, edibles, and cosmetics. It overlaps with Master Plant's CBD consumer goods vertical and competes for the same UK wholesale and white-label customers.
• Dragonfly CBD: Dragonfly CBD is a UK-based premium CBD wellness brand with broad retail distribution including Holland & Barrett. It is a direct competitor for CBD consumer goods shelf placement and brand positioning.
• Love Hemp: Love Hemp is one of the UK's largest CBD consumer goods brands, listed on the Aquis exchange. It competes for the same UK retail shelf space in tinctures, edibles, and wellness formats that Master Plant targets.
• Cellular Goods: UK-listed Cellular Goods produces lab-grown, cannabinoid-infused skincare and wellness products. It directly overlaps with Master Plant's cannabis wellness consumer goods positioning and shares the same London regulatory environment.
• Kanabo Group: London-listed Kanabo develops and distributes cannabis-derived wellness products and medical cannabis formulations in the UK and Germany. It is the closest UK-headquartered peer spanning CBD consumer goods and medical cannabis supply.

Emerging players

• Endoca: Endoca is a Europe-based CBD wellness producer with operations spanning hemp cultivation, extraction, and finished consumer products. It represents the vertically integrated hemp-to-CBD model Master Plant aspires to, with deeper operational maturity.
• Sapphire Medical Clinics: Sapphire Medical Clinics is the UK's first CQC-registered medical cannabis clinic and a downstream buyer of medical-grade cannabis products. It represents a potential B2B channel for Master Plant's medical/research supply vertical.
• Mamedica: Mamedica is a UK private medical cannabis clinic prescribing cannabis-based medicines to patients. It is a relevant adjacent channel for Master Plant's medical and research-supply positioning, though it is a buyer rather than direct product competitor.

Market position

Customer concentration

• LinkedInlinkedin.com/company/master-plant

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MASTER PLANT HOLDINGS LTD